Hemodynamic and metabolic effects of transjugular intrahepatic portosystemic shunt (TIPS) during anesthesia for orthotopic liver transplantation

Transpl Int. 1996;9(4):403-7. doi: 10.1007/BF00335703.

Abstract

Recently, the transjugular intrahepatic portosystemic shunt (TIPS) has been advocated as a safe bridge to orthotopic liver transplantation (OLT). We retrospectively studied 53 consecutive cirrhotic patients who underwent OLT: 27 patients with TIPS were compared to 26 controls. Hemodynamic and oxyphoretic data (Fick method) were collected during six phases of OLT. There were no significant differences in demographic data and Child-Pugh class, nor in surgical time and blood product requirements before the anhepatic phase between TIPS patients and controls. In the TIPS group, we observed a marked hyperdynamic profile with a lower systemic vascular resistance index, higher cardiac index, and depressed oxygen consumption before native liver removal. During the same period, the TIPS group developed a greater acidosis and was treated with a larger amount of NaHCO3. Following the anhepatic phase, no differences between the two groups were detected. All transplantations were successful, and no complications related to TIPS were observed. These results seem to be the consequence of a reduced liver function reserve with a direct hemodynamic effect due to the TIPS.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Acidosis / drug therapy
  • Acidosis / etiology
  • Adult
  • Anesthesia, General*
  • Ascites / etiology
  • Ascites / surgery*
  • Esophageal and Gastric Varices / etiology
  • Esophageal and Gastric Varices / surgery*
  • Female
  • Gastrointestinal Hemorrhage / etiology
  • Gastrointestinal Hemorrhage / surgery*
  • Hemodynamics*
  • Humans
  • Intraoperative Complications / drug therapy
  • Intraoperative Complications / etiology
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / surgery*
  • Liver Transplantation / methods*
  • Male
  • Middle Aged
  • Portasystemic Shunt, Transjugular Intrahepatic*
  • Retrospective Studies
  • Severity of Illness Index
  • Sodium Bicarbonate / therapeutic use
  • Stents
  • Treatment Outcome

Substances

  • Sodium Bicarbonate